Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review - Quiz - MDSpire

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review

  • By

  • Peng Tang

  • Weixing Liu

  • Yating Xu

  • You Long

  • Yixiao Li

  • Jiaxin Li

  • Mingheng Liao

  • Xin Wang

  • Jin Zhou

  • Yong Zeng

  • July 14, 2026

Share

Original Source(s)

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review

  • by Peng Tang, Weixing Liu, Yating Xu, You Long, Yixiao Li, Jiaxin Li, Mingheng Liao, Xin Wang, Jin Zhou, Yong Zeng

  • July 14, 2026

Related Content

Editorial: Molecular pathways and signaling molecules in cancer therapy: advances and innovations

Effects of donor killer-cell immunoglobulin-like receptor genotypes on clinical outcome after allogeneic hematopoietic stem cell transplantation—a systematic review and meta-analysis

A rare case report of gastric cancer complicated by ectopic drainage of the accessory common bile duct into the stomach and corresponding surgical strategies